Brought to you by 
Ethicon to acquire FemRx
13 Jul 1999
Executive Summary
Through a tender offer, Johnson & Johnson proposes to pay about $22mm in cash to acquire FemRx, a specialist in interventional gynecology devices. The company will become part of J&J's Ethicon surgical products unit.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com